Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  allogeneic T lymphocytes BPX-501
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant
Phase: Phase II, Phase I
Type: Treatment
Age: 18 to 65
Trial IDs: BP-HM-001, NCI-2013-00518, NCT01744223
Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases
Phase: Phase I
Type: Supportive care, Treatment
Age: 4 months to 54 years
Trial IDs: BP-003, NCI-2014-02100, NCT02231710
Start Over